PAA 2.63% 19.5¢ pharmaust limited

Moving Forward , The Countdown Begins, page-20

  1. 473 Posts.
    lightbulb Created with Sketch. 286
    Thanks Para!
    This highlights how much data is being prepared ready for phase 2 human trials, and with MND data being due soon, should fast track the human cancer trials prep and commencement.
    Existing external patents start expiring next year, so I see this as all good timing to progress.

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.